Lv4
476 积分 2024-07-19 加入
CDK4/6 inhibitor treatment for patients with hormone receptor-positive, HER2-negative, advanced or metastatic breast cancer: a US Food and Drug Administration pooled analysis
6天前
已完结
Safety profile of cyclin-dependent kinase (CDK) 4/6 inhibitors with concurrent radiation therapy: A systematic review and meta-analysis
6天前
已完结
Integrating radiation therapy with targeted treatments for breast cancer: From bench to bedside
6天前
已完结
Molecules Inducing Specific Cyclin-Dependent Kinase Degradation and their Possible Use in Cancer Therapy
10天前
已完结
Molecules Inducing Specific Cyclin-Dependent Kinase Degradation and their Possible Use in Cancer Therapy
10天前
已关闭
Molecules Inducing Specific Cyclin-Dependent Kinase Degradation and their Possible Use in Cancer Therapy
10天前
已关闭
Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer
12天前
已完结
Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology
12天前
已完结
The CDK4/6 inhibitor revolution — a game-changing era for breast cancer treatment
12天前
已完结
CDK4/6 inhibitors: The Devil is in the Detail
12天前
已完结
皖公网安备34019202002308
